ArticleBiology direct2009
The human Ago2 MC region does not contain an eIF4E-like mRNA cap binding motif.
Article in Biology direct, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
15 citing papers in PubMed, 37 citations in OpenAlex.
- Temporospatial guidance of activity-dependent gene expression by microRNA: mechanisms and functional implications for neural plasticity.Nucleic acids research · 2019Review
- MicroRNAs recruit eIF4E2 to repress translation of target mRNAs.Protein & cell · 2017Article
- Role of microRNAs in translation regulation and cancer.World journal of biological chemistry · 2017Review
- MicroRNA-mediated target mRNA cleavage and 3'-uridylation in human cells.Scientific reports · 2016Article
- Argonaute protein as a linker to command center of physiological processes.Chinese journal of cancer research = Chung-kuo yen cheng yen chiu · 2013Article
- eIF4GI facilitates the MicroRNA-mediated gene silencing.PloS one · 2013Article
- Kinetic signatures of microRNA modes of action.RNA (New York, N.Y.) · 2012Article
- The mechanics of miRNA-mediated gene silencing: a look under the hood of miRISC.Nature structural & molecular biology · 2012Review
- Article
- Human Ago2 is required for efficient microRNA 122 regulation of hepatitis C virus RNA accumulation and translation.Journal of virology · 2011Article
- Crystal structure and ligand binding of the MID domain of a eukaryotic Argonaute protein.EMBO reports · 2010Article
- How do miRNAs mediate translational repression?Silence · 2010Article
- Allosteric regulation of Argonaute proteins by miRNAs.Nature structural & molecular biology · 2010Article
- Poly(A)-binding protein modulates mRNA susceptibility to cap-dependent miRNA-mediated repression.RNA (New York, N.Y.) · 2010Article
- RNA interference in Trypanosoma brucei: role of the n-terminal RGG domain and the polyribosome association of argonaute.The Journal of biological chemistry · 2009Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 2 institutions in 1 country.
Funding
Abstract
backgroundArgonaute (Ago) proteins interact with small regulatory RNAs to mediate gene regulatory pathways. A recent report by Kiriakidou et al. 1 describes an MC sequence region identified in Ago2 that displays similarity to the cap-binding motif in translation initiation factor 4E (eIF4E). In a cap-bound eIF4E structure, two important aromatic residues of the motif stack on either side of a 7-methylguanosine 5'-triphosphate (m7Gppp) base. The corresponding Ago2 aromatic residues (F450 and F505) were hypothesized to perform the same cap-binding function. However, the detected similarity between the MC sequence and the eIF4E cap-binding motif was questionable.
resultsA number of sequence-based and structure-based bioinformatics methods reveal the reported similarity between the Ago2 MC sequence region and the eIF4E cap-binding motif to be spurious. Alternatively, the MC sequence region is confidently assigned to the N-terminus of the Ago piwi module, within the mid domain of experimentally determined prokaryotic Ago structures. Confident mapping of the Ago2 MC sequence region to the piwi mid domain results in a homology-based structure model that positions the identified aromatic residues over 20 A apart, with one of the aromatic side chains (F450) contributing instead to the hydrophobic core of the domain.
conclusionCorrect functional prediction based on weak sequence similarity requires substantial evolutionary and structural support. The evolutionary context of the Ago mid domain suggested by multiple sequence alignment is limited to a conserved hydrophobicity profile required for the fold and a motif following the MC region that binds guide RNA. Mapping of the MC sequence to the mid domain structure reveals Ago2 aromatics that are incompatible with eIF4E-like mRNA cap-binding, yet display some limited local structure similarities that cause the chance sequence match to eIF4E.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.